BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Isis Pharmaceuticals, Inc. 

Carlsbad Research Center
2292 Faraday Avenue
Carlsbad  California  92008-7208  U.S.A.
Phone: 760-931-9200 Fax: 760-603-4650


SEARCH JOBS

View Clinical Trials from BioPharm Insight



Industry
Biotechnology






 Company News
Isis Pharmaceuticals, Inc. (ISIS) To Present At The 13th Annual Needham Healthcare Conference 4/1/2014 6:21:41 AM    More...
Isis Pharmaceuticals, Inc. (ISIS) Announces Antisense Targeting Of HBV Produces Dose-Dependent Reductions In Hepatitis B Virus In An Animal Model Of HBV 3/24/2014 10:24:14 AM    More...
Isis Pharmaceuticals, Inc. (ISIS) Initiates Phase 1 Study Of ISIS-ANGPTL3 Rx To Treat Hyperlipidemia 3/19/2014 7:08:53 AM    More...
Isis Pharmaceuticals, Inc. (ISIS) To Present At The Barclays Global Healthcare Conference 3/6/2014 6:29:21 AM    More...
Isis Pharmaceuticals, Inc. (ISIS) Earns $1 Million From GlaxoSmithKline (GSK) For Advancing ISIS-TTR Rx 3/3/2014 11:18:09 AM    More...
Isis Pharmaceuticals, Inc. (ISIS) Reports Financial Results And Highlights For 2013 2/28/2014 8:08:33 AM    More...
Isis Pharmaceuticals, Inc. (ISIS) To Present At The Cowen and Company 34th Annual Health Care Conference 2/25/2014 6:22:51 AM    More...
Isis Pharmaceuticals, Inc. (ISIS) Touts Positive Phase 2 Spinal Muscular Atrophy Study Data 2/24/2014 11:39:33 AM    More...
Isis Pharmaceuticals, Inc. (ISIS) Reports Interim Results From ISIS-SMN Rx Multiple Dose Study In Children With Spinal Muscular Atrophy 2/21/2014 9:08:46 AM    More...
Webcast Alert: Isis Pharmaceuticals, Inc. (ISIS)' 2013 Financial Results And Highlights Conference Call 2/21/2014 6:31:06 AM    More...
12345678910...